Safety study of IVMED-85 eye drops in healthy adults
Part of Eyes & vision clinical trials.
This phase 1 trial tests the safety of an investigational eye drop called IVMED-85 in healthy adults aged 18-49. Participants will receive the eye drops and be monitored for any side effects over 6 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 49 years old.
- You must be generally healthy, with no major eye or health conditions.
- Your vision must be good (20/30 or better) in each eye.
- You must be willing to stop using other eye drops for the study (except artificial tears).
- You must not wear mascara or swim in an indoor pool for 6 weeks.
- You must not have a copper allergy or related condition (like Wilson's disease).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This study tests a new eye drop medicine to see if it is safe and how the body handles it. It is for healthy adults only, not for treating a condition.
This Phase 1/2 study tests the effectiveness and safety of an investigational eye drop (IVMED-85) for myopia (nearsightedness) in children. It may help slow how quickly nearsightedness gets worse, but eligibility is limited to specific eye measurements.
This early-stage study tests a new eye ointment called RC017 to see how safe it is and how the body handles it. Healthy volunteers will apply the ointment to their eyes once or multiple times so researchers can check for any side effects.
This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.
This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.
Hear when a new Safety Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.